Careers Media center Contacts

Rhinohermina and Narivent produced by D.M.G. Italy is registered in Uzbekistan

Rhinohermina and Narivent produced by D.M.G. Italy is registered in Uzbekistan

30 September 2020 | News

Arterium Corporation has registered two medical devices in Uzbekistan - Rhinohermin and Narivent sprays. Uzbekistan became the second country (after Ukraine) where Arterium registered products of this category for the first time. Rhinohermina and Narivent are innovative products manufactured by the Italian company D.M.G. Italy. Narivent spray eliminates edema and has an anti-inflammatory effect, Rhinohermina forms a biological barrier on the nasal mucosa against microorganisms that cause disease. Both sprays are already used in Italy, Spain, Bulgaria, Hungary, Poland, the Czech Republic, Romania and other EU countries, Turkey, Lebanon and Ukraine.
According to Serhiy Sur, Director of Regulatory Interaction, Arterium plans to register Narvent and Rhinozhermin VMPs in Belarus and Kazakhstan as well. Development of export sales is one of the key strategic directions for Arterium Corporation. Today the company exports its products to 12 countries.

Media gallery
PRESS KIT

Here you can find general information about the company intended for journalists and other stakeholders

MEDIA CONTACTS

For all media-related enquiries,
please contact us
e-mail: pr@arterium.ua
mob.: +38050 446 71 20, +38095 278 92 80